These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28885037)

  • 1. Will Biosimilar Insulins Be Cheaper?
    Heinemann L; Carter AW
    Diabetes Technol Ther; 2017 Sep; 19(9):513-515. PubMed ID: 28885037
    [No Abstract]   [Full Text] [Related]  

  • 2. Biosimilar vs originator insulins: Systematic review and meta-analysis.
    Yamada T; Kamata R; Ishinohachi K; Shojima N; Ananiadou S; Nom H; Yamauchi T; Kadowaki T
    Diabetes Obes Metab; 2018 Jul; 20(7):1787-1792. PubMed ID: 29536603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Biosimilar Insulins: A US Perspective.
    Zhang RM; Puri R; McGill JB
    BioDrugs; 2020 Aug; 34(4):505-512. PubMed ID: 32681425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New Insulins for Type 1 Diabetes treatment].
    Rumié Carmi HK; Domínguez-Menéndez G; Araya M; Martínez-Aguayo A
    Andes Pediatr; 2023 Jun; 94(3):278-285. PubMed ID: 37909930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulary Considerations for Insulins Approved Through the 505(b)(2) "Follow-on" Pathway.
    Rasmussen JT; Ipema HJ
    Ann Pharmacother; 2019 Feb; 53(2):204-210. PubMed ID: 30122087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of biosimilar insulins in Europe.
    Davies M; Dahl D; Heise T; Kiljanski J; Mathieu C
    Diabet Med; 2017 Oct; 34(10):1340-1353. PubMed ID: 28608570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Bolinder J
    Diabetes Technol Ther; 2018 Feb; 20(S1):S55-S70. PubMed ID: 29437477
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of breast cancer by individual insulin use: an international multicenter study.
    Grimaldi-Bensouda L; Cameron D; Marty M; Barnett AH; Penault-Llorca F; Pollak M; Charbonnel B; Riddle M; Mignot L; Boivin JF; Khachatryan A; Rossignol M; Bénichou J; Alpérovitch A; Abenhaim L;
    Diabetes Care; 2014; 37(1):134-43. PubMed ID: 23949559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin biosimilars: the impact on rapid-acting analogue-based therapy.
    Franzè S; Cilurzo F; Minghetti P
    BioDrugs; 2015 Apr; 29(2):113-21. PubMed ID: 25773234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosimilar Insulin and Costs: What Can We Expect?
    Heinemann L
    J Diabetes Sci Technol; 2015 Sep; 10(2):457-62. PubMed ID: 26350722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosimilar insulins are coming: what they are, what you need to know.
    Edelman S; Polonsky WH; Parkin CG
    Curr Med Res Opin; 2014 Nov; 30(11):2217-22. PubMed ID: 25105307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of two insulin glargine formulations: biosimilar vs. reference product].
    Mönnig E; Schloot N; Hohberg C; Wiesner T; Heinemann L
    MMW Fortschr Med; 2016 Aug; 158 Suppl 5():19-27. PubMed ID: 27565486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrated insulins in current clinical practice.
    Schloot NC; Hood RC; Corrigan SM; Panek RL; Heise T
    Diabetes Res Clin Pract; 2019 Feb; 148():93-101. PubMed ID: 30583034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosimilar insulins are coming: the top 10 things you should know.
    Blumer I; Edelman S
    Postgrad Med; 2014 May; 126(3):107-10. PubMed ID: 24918796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump.
    Thrasher J; Surks H; Nowotny I; Pierre S; Rotthaeuser B; Wernicke-Panten K; Garg S
    J Diabetes Sci Technol; 2018 May; 12(3):680-686. PubMed ID: 29359575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Bolinder J
    Diabetes Technol Ther; 2017 Feb; 19(S1):S42-S58. PubMed ID: 28192016
    [No Abstract]   [Full Text] [Related]  

  • 17. SAR342434 - an insulin biosimilar for the treatment of type II diabetes.
    Hu J; Wang M; Zhao Y
    Expert Opin Biol Ther; 2018 Nov; 18(11):1107-1112. PubMed ID: 30295083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Insulins and New Aspects in Insulin Delivery.
    Woo VC
    Can J Diabetes; 2015 Aug; 39(4):335-43. PubMed ID: 26233724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.
    Dunn CJ; Plosker GL
    Pharmacoeconomics; 2002; 20(14):989-1025. PubMed ID: 12403639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher concentration insulins: an overview of clinical considerations.
    Reid TS; Schafer F; Brusko C
    Postgrad Med; 2017 Jun; 129(5):554-562. PubMed ID: 28475455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.